FDA product records
Some peptide medicines are approved
The US government agency that reviews medicines for approval is called the Food and Drug Administration (FDA).
FDA approval means the agency reviewed a specific medicine for particular health needs.
As of September 26, 2026, approved US products include tirzepatide (Mounjaro, Zepbound) as well as semaglutide (Ozempic, Wegovy).
Ask which product and form is being discussed, and for what purpose.
Read the semaglutide product labelFDA records and statement
Familiar names need another check
FDA approval records checked September 26, 2026 showed that BPC-157, ipamorelin and retatrutide had no approved US product.
As of that same date, federal law does not permit compounding retatrutide or cagrilintide, according to the FDA.
A name appearing often in adverts does not tell you whether that medicine has FDA approval.
Read the FDA’s statement on these drugsWhat about a government database code?
NDC stands for National Drug Code. A government list uses this number to identify a drug product.
The FDA says this number does not prove approval or permission to sell the product, as checked September 26, 2026.
- Which FDA product record supports the claim being made?
- Is the offer for an approved product or a compounded preparation?
- What is still unknown about this exact preparation?